SNWV - SANUWAVE Health, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1600
0.0000 (0.00%)
At close: 2:47PM EST
Stock chart is not supported by your current browser
Previous Close0.1600
Open0.1475
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1400 - 0.1600
52 Week Range0.1000 - 0.3300
Volume282,853
Avg. Volume231,655
Market Cap43.025M
Beta (3Y Monthly)-1.88
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • SNWV: NGS Reimbursement Update Should Catalyze U.S. Adoption, Procedure Revenue
    Zacks Small Cap Research

    SNWV: NGS Reimbursement Update Should Catalyze U.S. Adoption, Procedure Revenue

    By Brian Marckx, CFA OTC:SNWV READ THE FULL SNWV RESEARCH REPORT Q2 Results, Operational Update : Record U.S. Product Sales. NGS Update Should Help Drive Adoption, Procedure Revenue …. SANUWAVE (OTC:SNWV) reported financial results for their second quarter ending June 30th and provided a business update. As it relates to the financials, while revenue

  • Insiders Roundup: Facebook, Community Health Systems
    GuruFocus.com

    Insiders Roundup: Facebook, Community Health Systems

    Largest insider buys Continue reading...

  • Zacks Small Cap Research

    SNWV U.S. Roll-Out Strategy Coming Together, Placement Guidance Raised 10% to 110 Units

    Q1 Results, Operational Update: International Sales Disappoint But U.S. Strategy Coming Together. SANUWAVE (SNWV) reported financial results for their first quarter ending March 31st and provided a business update. Recognition of licensing fees, related to upfront and subsequent payments under recently-penned joint venture and OUS distribution agreements, has helped buoy international sales.

  • Zacks Small Cap Research

    SNWV: Strong Finish to 2018. U.S. Roll-Out Underway, Guiding for 100 Placements in 2019

    SANUWAVE (SNWV) announced Q4 / full-year 2018 financial results and provided a business update. Continued progress with putting the U.S. commercialization strategy in place means domestic revenue should begin to accelerate later this year. Meanwhile, expansion of the international footprint and increasing sales in existing territories should benefit OUS revenue growth.